Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients.
about
What is the evidence base for diagnosing hypertension and for subsequent blood pressure treatment targets in the prevention of cardiovascular disease?Differences between clinic blood pressure and morning home blood pressure, as shown by Bland-Altman plots, in a large observational study (HONEST study).Chronic hyperglycemia increases the risk of lateral epicondylitis: the Locomotive Syndrome and Health Outcome in Aizu Cohort Study (LOHAS)Common variants of the G protein-coupled receptor type 4 are associated with human essential hypertension and predict the blood pressure response to angiotensin receptor blockade.Home blood pressure and cardiovascular risk in treated hypertensive patients: the prognostic value of the first and second measurements and the difference between them in the HONEST study.Comparisons of home and daytime ambulatory blood pressure measurements.Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial.Orthostatic hypertension: home blood pressure monitoring for detection and assessment of treatment with doxazosin.A retrospective, cross-sectional study of real-world values of cardiovascular risk factors using a healthcare database in Japan.Hypertension resistant to antihypertensive agents commonly occurs with the progression of diabetic nephropathy in Japanese patients with type 2 diabetes mellitus: a prospective observational studyAbnormality of risk factors for atherosclerotic disease among young Japanese aged 19-39 years old: an evaluation of health checkup dataCombination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.Randomized trial comparing the velocities of the antihypertensive effects on home blood pressure of candesartan and candesartan with hydrochlorothiazide.The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics.Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trialAssociation between pre-hypertension and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies.Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability.Effectiveness of olmesartan-based treatment on home and clinic blood pressure in elderly patients with masked and white coat hypertension.Sodium intake in men and potassium intake in women determine the prevalence of metabolic syndrome in Japanese hypertensive patients: OMEGA StudyC-reactive protein levels, airflow obstruction, and chronic kidney diseaseMacrophage migration inhibitory factor urinary excretion revisited – MIF a potent predictor of the immunosuppressive treatment outcomes in patients with proliferative primary glomerulonephritisThe central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain.Association between frequency of drinking alcohol and chronic kidney disease in men.Association of severe hypertension with pneumonia in elderly patients with acute ischemic strokePreferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis.Long-term safety and efficacy of high-dose controlled-release nifedipine (80 mg per day) in Japanese patients with essential hypertension.Three-year safety and effectiveness of fixed-dose losartan/hydrochlorothiazide combination therapy in Japanese patients with hypertension under clinical setting (PALM-1 Extension Study)Relationship between achieved blood pressure, dietary habits and cardiovascular disease in hypertensive patients treated with olmesartan: the OMEGA study.Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial.The effects of continuing and discontinuing smoking on the development of chronic kidney disease (CKD) in the healthy middle-aged working population in Japan.Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study.Maternal and paternal family history of type 2 diabetes differently influence lipid parameters in young nondiabetic Japanese womenA U-shaped relationship between alcohol consumption and cardiometabolic index in middle-aged men.Four to seven random casual urine specimens are sufficient to estimate 24-h urinary sodium/potassium ratio in individuals with high blood pressure.Persistent olmesartan-based blood pressure-lowering effects on morning hypertension in Asians: the HONEST study.Distribution of and factors contributing to chronic kidney disease in a middle-aged working population.Effect of the angiotensin II receptor antagonist olmesartan on morning home blood pressure in hypertension: HONEST study at 16 weeks.Effects of dual blockade of the renin-angiotensin system on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy and hypertension in the ORIENT: a post-hoc analysis (ORIENT-Hypertension).Obstructive sleep apnea syndrome and hypertension: mechanism of the linkage and 24-h blood pressure control.Obstructive sleep apnea syndrome and hypertension: ambulatory blood pressure.
P2860
Q26784487-3A1C32C2-B1D6-4081-8876-85979D724F0CQ27323117-8773AA2D-8499-4C75-BD39-73C9D8A4F006Q28385385-47697780-3042-48C7-8E6A-A01FA5223671Q30300484-6D08E099-33DD-4D6B-8AD7-8A81FAECDDBAQ33895476-681CF470-332B-4E1E-8B29-6B537CFE488DQ34051170-055333BC-8E8A-4BFA-8C40-E244EDCEB7A3Q34196851-F76A3407-6265-424B-912B-31CECAA58F53Q34216489-FED9D2A2-081E-4EC5-BA28-970F34B4DF15Q34267358-9CCDB11C-5457-4703-AB9D-059887671A4FQ34318842-2923426B-7316-4608-802A-1A6AC3231E36Q34325184-59331C8F-962D-4227-A5E3-2F0A932858A6Q34635806-197F44A4-5C96-4A6F-ADDA-18F05B8A3444Q34670268-C3C79D4D-F1FA-47EE-98A1-F2D1A5DABD0CQ34699614-E2E160F8-98A9-444A-9ADB-80A33F69E215Q34876994-CC10397F-6C4D-40FF-9483-BDB87B9B5762Q35043348-F036A627-D85F-415B-84FF-A0047C0940D0Q35065309-39D58FB7-0CDD-45BD-8BFA-322894F73DDFQ35152926-EF3B9CFD-2735-4B30-AC7A-7104C3722DB3Q35669288-5FB9F2E7-C20F-4E9C-A6AA-117C1092E45EQ35672663-454C09C7-D25E-4700-A3DF-6BFAEEFF5E22Q35745565-34AB3CAC-62BE-4DE8-8673-2024D6656C33Q35883217-99043586-A780-4B74-9065-EC801D9E2094Q35946447-5B8D78DE-5AC5-4A45-9CFD-7BFC0E068F76Q36011117-87B1E06B-DEFE-449D-86B7-C2220C7DEBF0Q36061968-A7C4BA4A-D0DA-4B92-AC54-B60EA1F88432Q36137862-B9D25D3D-A4FF-42DA-85A0-E6B07E572006Q36425842-C00AF200-7767-4266-87F8-D81BC99744A0Q36451795-13E0FA27-B204-4188-8B63-81F029F566F2Q36453062-C6A172F9-4D40-4436-9136-1530BE73F977Q36523279-9CE478F5-5D83-4E23-AFF6-4C7FF1446245Q36589337-DDDAB6D3-C49C-4A28-A964-1A62332ACB37Q36662473-0BF191E6-437E-4455-9EC6-9BF4004DD5F1Q36668094-D7885B96-0B3D-49A6-8ED2-3DD2DD640263Q36784995-E9F01530-C5B6-42BD-B147-DDF2B7269348Q36896791-0E990F15-6A30-496B-932F-DCA1DCAB1BE6Q37299788-D930F0F5-FC6F-4315-A9B9-F806C5ABFDD0Q37317689-2BD56DD4-8E3C-4F32-9286-02F50EE74F8BQ37369476-AFA98B0A-919D-4411-8B05-869C8FAF78E4Q37492226-1CF15A84-2176-4EAE-8E2D-E7BA547C77AEQ37507500-7381ED89-45BD-446B-8BD0-6E15C3F6E88F
P2860
Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Rationale, study design and im ...... elderly hypertensive patients.
@en
Rationale, study design and im ...... elderly hypertensive patients.
@nl
type
label
Rationale, study design and im ...... elderly hypertensive patients.
@en
Rationale, study design and im ...... elderly hypertensive patients.
@nl
prefLabel
Rationale, study design and im ...... elderly hypertensive patients.
@en
Rationale, study design and im ...... elderly hypertensive patients.
@nl
P2093
P2860
P356
P1476
Rationale, study design and im ...... elderly hypertensive patients
@en
P2093
COLM study investigators
Hiroaki Matsuoka
Ikuo Saito
Jitsuo Higaki
Kazuaki Shimamoto
Kazuyuki Shimada
Masatsugu Horiuchi
Shigehiro Katayama
Shuichi Takishita
Takao Saruta
P2860
P2888
P304
P356
10.1038/HR.2008.31
P577
2009-01-23T00:00:00Z